Quantification of mast cells in different stages of periodontal disease

  • Dragan Marjanović Dental Clinic, Faculty of Medicine, University of Kosovska Mitrovica, Kosovska Mitrovica, Serbia
  • Zlatibor Anđelković Institute for Histology and Embryology, Faculty of Medicine, University of Kosovska Mitrovica, Kosovska Mitrovica, Serbia
  • Zlata Brkić Dental Clinic, Military Medical Academy, Belgrade, Serbia; §Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade, Serbia
  • Goran Videnović Dental Clinic, Faculty of Medicine, University of Kosovska Mitrovica, Kosovska Mitrovica, Serbia
  • Meliha Šehalić Dental Clinic, Faculty of Medicine, University of Kosovska Mitrovica, Kosovska Mitrovica, Serbia
  • Vladimir Matvijenko Dental Clinic, Faculty of Medicine, University of Kosovska Mitrovica, Kosovska Mitrovica, Serbia
  • Snežana Leštarević Dental Clinic, Military Medical Academy, Belgrade, Serbia
  • Nadica Đorđević Dental Clinic, Faculty of Medicine, University of Kosovska Mitrovica, Kosovska Mitrovica, Serbia
Keywords: periodontal diseases, disease progression, mast cells,

Abstract


Background/Aim. Mast cells are mononuclear cells originating from bone marrow. They produce various biologically active substances, which allow them to actively participate in immune and inflammatory processes associated with periodontal disease. The study focused on distribution and density of mast cells in healthy gingiva as well as in different stages of periodontal disease. Methods. The material used for this purpose was gingival biopsies taken from 96 patients classified into 4 groups: healthy gingiva, gingivitis, initial and severe periodontal disease. Toluidine blue staining according to Spicer was utilized for identifying mast cells. Results. Basing on our study, the density of mast cells in the gingival tissue increases with the progression of the infection, which means they are more numerous in gingivitis compared to healthy gingiva, as well as in periodontal disease compared to gingivitis. Conclusion. Increase in the number of mast cells in the infected gingiva can be correlated with an increased influx of inflammatory cells from blood circulation into the gingival stroma, as well as with the collagen lysis, since these cells produce substances with collagenolytic potential. Based on the distribution of mast cells, it could be concluded that in the evolution of periodontal disease there are significant dynamic alterations in migration and localization of these cells.

 


References

Di Benedetto A, Gigante I, Colucci S, Grano M. Periodontal disease: linking the primary inflammation to bone loss. Clin Dev Immunol 2013; 2013: 503754.

Kinney JS, Ramseier CA, Giannobile WV. Oral fluid-based bi-omarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci 2007; 1098: 230−51.

Younes R, Ghorra C, Khalife S, Igondjo-Tchen-Changotade S, Yousfi M, Willig C, et al. Pertinent cell population to characterize per-iodontal disease. Tissue Cell 2009; 41(2): 141−50.

Saremi A, Nelson RG, Tulloch-Reid M, Hanson RL, Sievers ML, Taylor GW, et al. Periodontal disease and mortality in type 2 di-abetes. Diabetes Care 2005; 28(1): 27−32.

Graves D. Cytokines that promote periodontal tissue destruc-tion. J Periodontol 2008; 79(8 Suppl): 1585−91.

Garlet GP, Cardoso CR, Mariano FS, Claudino M, de Assis GF, Campanelli AP, et al Regulatory T cells attenuate experimental periodontitis progression in mice. J Clin Periodontol 2009; 37(7): 591−600.

Puxeddu I, Piliponsky AM, Bachelet I, Levi-Schaffer F. Mast cells in allergy and beyond. Int J Biochem Cell Biol 2003; 35(12): 1601−7.

Termei R, Laschinger C, Lee W, McCulloch CA. Intercellular inter-actions between mast cells and fibroblasts promote pro-inflammatory signaling. Exp Cell Res 2013; 319(12): 1839−51.

Lagdive SS, Lagdive SB, Mani A, Anarthe R, Pendyala G, Pawar B, et al. Correlation of mast cells in periodontal diseases. J Indian Soc Periodontol 2013; 17(1): 63−7.

Kheur S, Patekar D, Bagul N, Kulkarni M, Routray S, Dhas V. Role of Mast Cell in Oral Pathology. Oral Maxillofac Pathol J 2013; 4(1): 320−5.

Naesse EP, Schreurs O, Helgeland K, Schenck K, Steinsvoll S. Matrix metalloproteinases and their inhibitors in gingival mast cells in persons with and without human immunodeficiency virus in-fection. J Periodont Res 2003; 38(6): 575−82.

Irani AM, Goldstein SM, Wintroub BU, Bradford T, Schwartz LB. Human mast cell carboxypeptidase. Selective localization to MCTC cells. J Immunol 1991; 147(1): 247−53.

Irani AM, Bradford TR, Kepley CL, Schechter NM, Schwartz LB. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 1989; 37(10): 1509−15.

Armitage GC. Periodontal diagnoses and classification of peri-odontal diseases. Periodontology 2000 2004; 34(1): 9−21.

Spicer SS. Diamine methods for differentiating mucosubstances histochemically. J Histochem Cytochem 1965; 13(3): 211−34.

Popovici R, Ceausu R, Cimpean A, Serban T, Raica M, Gaje P. Mast cells as key players in periodontal disease. Arch Biol Sci 2014; 66(2): 801−9.

Scott DT, Lam FY, Ferrell WR. Acute joint inflammation--mechanisms and mediators. Gen Pharmacol 1994; 25(7): 1285−96.

Huang S, Lu F, Chen Y, Huang B, Liu M. Mast cell degranulation in human periodontitis. J Periodontol 2013; 84(2): 248−55.

Mekori YA, Metcalfe DD. Mast cell–T cell interactions. J Allergy Clin Immunol 1999; 104(3): 517−23.

Malaviya R, Twesten NJ, Ross EA, Abraham SN, Pfeifer JD. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 1996; 156(4): 1490−6.

Batista AC, Rodini CO, Lara VS. Quantification of mast cells in different stages of human periodontal disease. Oral Dis 2005; 11(4): 249−54.

Gurish MF, Boyce JA. Mast cell growth, differentiation, and death. Clin Rev Allergy Immunol 2002; 22(2): 107−18.

Walsh LJ, Davis MF, Xu LJ, Savage NW. Relationship between mast cell degranulation and inflammation in the oral cavity. J Oral Pathol Med 1995; 24(6): 266−72.

Kennett CN, Cox SW, Eley BM, Osman IA. Comparative histo-chemical and biochemical studies of mast cell tryptase in hu-man gingiva. J Periodontol 1993; 64(9): 870−7.

Helton LE, Hall WB. Human gingival mast cells. Effects of chronic inflammation. J Periodont Res 1968; 3(3): 214−23.

Gemmell E, Carter CL, Seymour GJ. Mast cells in human perio-dontal disease. J Dent Res 2004; 83(5): 384−7.

Cindrić N, Tamarut T, Jonjić N. Quantitative analysis of mast cells in normal and inflamed human gingiva. Acta Fac Med Flumin 1991; 16(1−2): 1−6.

Wislocki GB, Sognnaes RF. Histochemical reactions of normal teeth. Am J Anat 1950; 87(2): 239−75.

Dummett CO, Bolden TE, Ashhurst JC. Mast-Cell Density in Di-phenylhydantoin Sodium Gingival Hyperplasia. J Dent Res 1961; 40(5): 921−8.

Benditt EP, Bader S, Lam KB. Studies of the mechanism of acute vascular reactions to injury. I. The relationship of mast cells and histamine to the production of edema by ovomucoid in rats. AMA Arch Pathol 1955; 60(1): 104−15.

Aeschlimann CR, Kaminski EJ, Robinson PJ. The effects of perio-dontal therapy on the mast cell population in gingival tissues. J Periodontol 1980; 51(4): 193−8.

Chiappetta N, Gruber B. The role of mast cells in osteoporosis. Semin Arthritis Rheum 2006; 36(1): 32−6.

Published
2017/03/07
Section
Original Paper